Phase Ib/II Study of Enzalutamide With Venetoclax (ABT-199) in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 22 Jan 2019
At a glance
- Drugs Enzalutamide (Primary) ; Venetoclax (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jan 2019 Planned initiation date changed from 30 Dec 2018 to 1 Feb 2019.
- 12 Dec 2018 Planned initiation date changed from 30 Nov 2018 to 30 Dec 2018.
- 28 Nov 2018 New trial record